If you are losing weight without: Strength training Eating enough protein Following a structured fitness plan you may lose a significant amount of muscle tissue along with body fat
4-in-1 Multi-peptide synergy providing complete healing across tissue repair, inflammation, immunity, and regeneration pathways Proven Each component individually validated through clinical research, combined in optimal ratios for maximum benefit Questions Quad Healing Blend combines four peptides in precise ratios designed to create synergistic effects where each component enhances the others therapeutic benefits
Luthione is a top-notch skin whitening injection that is suitable for both men and women
Clinical data show that MHRA received 7,228 reports of gastrointestinal reactions with GLP-1 receptor agonists, whilst independent testing of unregulated peptides revealed significant purity discrepancies, with some products showing purity levels as low as 1.7% compared to supplier claims
Our Myers Cocktail, Immune Boost, and THE EDGE IVs are popular with convention attendees who need to stay sharp and healthy throughout a demanding week
Published literature: Documented effects on sleep architecture and cortisol modulation in published studies Therapeutic Peptides Comparison Table Peptide Category FDA Status Primary Research Application BPC-157 Tissue Repair Category 1 (2026) Tendon, ligament, GI repair TB-500 Tissue Repair Category 1 (2026) Soft tissue, cell migration Retatrutide Metabolic Phase 3 trials Obesity, metabolic syndrome Tirzepatide Metabolic FDA-approved Type 2 diabetes, obesity Tesamorelin Metabolic / GH FDA-approved Lipodystrophy, visceral fat GHK-Cu Skin / Repair Not approved Wound healing, collagen CJC-1295 GH Secretagogue Category 1 (2026) Growth hormone release Ipamorelin GH Secretagogue Category 1 (2026) Selective GH release Selank Cognitive Category 1 (2026) Anxiety, GABA modulation Semax Cognitive Category 1 (2026) Memory, BDNF pathways KPV Anti-inflammatory Not approved Gut inflammation, skin PT-141 Neurological FDA-approved Sexual health (HSDD) SS-31 Mitochondrial FDA-approved Barth syndrome, mito dysfunction MOTS-c Mitochondrial Not approved Insulin sensitivity, exercise Humanin Cytoprotective Not approved Neuroprotection, aging DSIP Neurological Not approved Sleep regulation 2026 FDA Peptide Reclassification On February 27, 2026, HHS Secretary Robert F
